ID: ALA3105027

Max Phase: Preclinical

Molecular Formula: C31H34O6

Molecular Weight: 502.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1OC(=O)c1ccc2ccccc2c1)[C@H]1[C@@H](C[C@H]3C)C1(C)C

Standard InChI:  InChI=1S/C31H34O6/c1-16-14-30-17(2)11-23-24(29(23,3)4)22(26(30)34)13-21(15-32)25(33)31(30,36)27(16)37-28(35)20-10-9-18-7-5-6-8-19(18)12-20/h5-10,12-14,17,22-25,27,32-33,36H,11,15H2,1-4H3/t17-,22+,23-,24+,25-,27+,30+,31+/m1/s1

Standard InChI Key:  IXYHNFDSJUFSHJ-ACECJHEDSA-N

Associated Targets(Human)

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein kinase C delta 2953 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MT4 17854 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

U-937 7138 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 70413 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 502.61Molecular Weight (Monoisotopic): 502.2355AlogP: 3.83#Rotatable Bonds: 3
Polar Surface Area: 104.06Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.13CX Basic pKa: CX LogP: 3.78CX LogD: 3.78
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.44Np Likeness Score: 2.48

References

1. Grue-Sørensen G, Liang X, Månsson K, Vedsø P, Dahl Sørensen M, Soor A, Stahlhut M, Bertelsen M, Engell KM, Högberg T..  (2014)  Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer.,  24  (1): [PMID:24332494] [10.1016/j.bmcl.2013.11.073]
2. Liu Q, Li W, Huang L, Asada Y, Morris-Natschke SL, Chen CH, Lee KH, Koike K..  (2018)  Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansui.,  156  [PMID:30031972] [10.1016/j.ejmech.2018.07.020]

Source